AI Article Synopsis
- The COVID-19 pandemic led to a rapid shift from in-person to telehealth care, impacting how patients with chronic conditions like type 2 diabetes received treatment.
- During the first 9 months of the pandemic, there were notable declines in primary care visits, A1C testing rates, and patients meeting A1C guidelines.
- Those most affected included patients with only telehealth visits, those who didn't seek care at all, and individuals from racial or ethnic minority groups, particularly those with Medicaid or no insurance, who were more likely to miss A1C tests.
Article Abstract
The coronavirus disease 2019 (COVID-19) pandemic instigated major changes in care delivery, but our understanding of how the rapid transition from in-person to telehealth encounters affected the care of patients with chronic conditions such as type 2 diabetes remains incomplete. This study examined changes in primary care encounters, A1C testing rates, and the likelihood of meeting A1C guidelines before and during the first 9 months of the COVID-19 pandemic in a large health care system. It found significant decreases in utilization and testing rates and the likelihood of meeting A1C guidelines, primarily driven by missing A1C tests. Patients who had all telehealth encounters or no encounters, who identified as racial or ethnic minorities, or had Medicaid or no insurance were significantly more likely to miss A1C tests.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606553 | PMC |
| http://dx.doi.org/10.2337/cd21-0116 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!